Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. (Q36721748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Shuk-Mei Ho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Irving Chung

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

1089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

177-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

Human prostate cancer risk factors

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Use of relative weight and Body Mass Index for the determination of adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Estrogens and prostatic disease. International Prostate Health Council Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Comparative study of glycoconjugates of the rat prostatic lobes by lectin histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

21 January 2018

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Estrogen receptor transcription and transactivation: Basic aspects of estrogen action

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Role of estrogen receptor beta in estrogen action

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Estrogen receptor beta in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

A role for estrogen receptor beta in the regulation of growth of the ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Generation and reproductive phenotypes of mice lacking estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Estrogens in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Endocrine treatment in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1386.005

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1386.005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17261766%20AND%20SRC:MED&resulttype=core&format=json